Anavex Life Sciences
AVXL
53 hedge funds and large institutions have $16.6M invested in Anavex Life Sciences in 2016 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 22 increasing their positions, 10 reducing their positions, and 4 closing their positions.
175% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 4
120% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 10
15% more funds holding
Funds holding: 46 → 53 (+7)
29% less capital invested
Capital invested by funds: $23.4M → $16.6M (-$6.75M)
77% less call options, than puts
Call options by funds: $332K | Put options by funds: $1.46M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Northern Trust
Chicago,
Illinois
|
+$1.05M |
| 2 |
State Street
Boston,
Massachusetts
|
+$919K |
| 3 |
D.E. Shaw & Co
New York
|
+$442K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$432K |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$154K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$409K |
| 2 |
Group One Trading
Chicago,
Illinois
|
-$158K |
| 3 |
V
Veritable
Wilmington,
Delaware
|
-$153K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$111K |
| 5 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$69.2K |
AVXL Hedge Fund Activity: Q3 2016 in Review
53 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in Anavex Life Sciences (AVXL) for Q3 2016, worth a combined $16.6M — down 29% from $23.4M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new AVXL positions and 4 closed out — a net gain of 7 holders — while 22 added to existing stakes and 10 trimmed.
The largest buyer was Northern Trust, adding an estimated $1.05M. The largest seller was Bank of America, cutting an estimated $409K.
- 53 institutional investors held Anavex Life Sciences (AVXL) as of Q3 2016, up from 46 in Q2 2016.
- Funds reported $16.6M of Anavex Life Sciences stock for Q3 2016, down 29% quarter-over-quarter.
- 11 funds opened new Anavex Life Sciences positions in Q3 2016 and 4 closed out, a net change of +7 holders.
- The largest Anavex Life Sciences buyer in Q3 2016 was Northern Trust, an estimated $1.05M added.
- The largest Anavex Life Sciences seller in Q3 2016 was Bank of America, an estimated $409K sold.
Based on aggregated 13F filings for Q3 2016.